SAVA - Cassava Sciences Cooperates With DOJ SEC On Controversial Alzheimer's Drug Investigation | Benzinga
Cassava Sciences (NASDAQ:SAVA) has engaged the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) amid ongoing investigations into the company and two senior employees.
Cassava’s board formed an Ad Hoc Investigation Committee to oversee outside counsel conducting the investigation. The Committee also oversees the company’s disclosures related to the investigation, the company said in an SEC filing.
On Friday, the DOJ announced an indictment against Dr. Hoau-Yan Wang, alleging he submitted fraudulent grant applications to the National Institutes of Health.
The indictment claims Dr. Wang made false ...